Idera Pharmaceuticals Inc
F:HXXB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Idera Pharmaceuticals Inc
F:HXXB
|
US |
|
H
|
Hubei Goto Biopharm Co Ltd
SZSE:300966
|
CN |
|
A Plus Asset Advisor Co Ltd
KRX:244920
|
KR |
|
Kanani Industries Ltd
NSE:KANANIIND
|
IN |
|
Jensen Group NV
LSE:0EX6
|
BE |
|
Prudential PLC
LSE:PRU
|
UK |
|
Otsuka Holdings Co Ltd
TSE:4578
|
JP |
|
E
|
ESAB Corp
NYSE:ESAB
|
US |
|
Gujarat State Petronet Ltd
NSE:GSPL
|
IN |
|
N
|
Nike Inc
BMV:NKE
|
US |
|
Elior Group SA
PAR:ELIOR
|
FR |
|
Weilong Grape Wine Co Ltd
SSE:603779
|
CN |
|
V
|
Vas Infrastructure Ltd (cn)
BSE:531574
|
IN |
|
V
|
Verkkokauppa.com Oyj
OMXH:VERK
|
FI |
|
Bunge Ltd
NYSE:BG
|
US |
|
Rain Industries Ltd
BSE:500339
|
IN |
|
H
|
Hwa Create Corp
SZSE:300045
|
CN |
|
V
|
Vision International Holdings Ltd
HKEX:8107
|
HK |
|
G
|
Global Petroleum Ltd
LSE:GBP
|
AU |
|
Playfair Mining Ltd
XTSX:PLY
|
CA |
|
Natwest Group PLC
LSE:NWG
|
UK |
|
Odawara Engineering Co Ltd
TSE:6149
|
JP |
|
MRC Global Inc
NYSE:MRC
|
US |
|
S
|
Sundiro Holding Co Ltd
SZSE:000571
|
CN |
Income Statement
Earnings Waterfall
Idera Pharmaceuticals Inc
Income Statement
Idera Pharmaceuticals Inc
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
0
N/A
|
0
N/A
|
5
N/A
|
|
| Operating Income | ||||
| Operating Expenses |
(37)
|
(26)
|
(24)
|
|
| Selling, General & Administrative |
(12)
|
(10)
|
(12)
|
|
| Research & Development |
(25)
|
(16)
|
(12)
|
|
| Operating Income |
(37)
N/A
|
(26)
+28%
|
(20)
+26%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
7
|
1
|
|
| Non-Reccuring Items |
0
|
(1)
|
(8)
|
|
| Total Other Income |
(76)
|
119
|
(2)
|
|
| Pre-Tax Income |
(113)
N/A
|
98
N/A
|
(30)
N/A
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
6
|
|
| Income from Continuing Operations |
(113)
|
98
|
(23)
|
|
| Net Income (Common) |
(113)
N/A
|
97
N/A
|
(23)
N/A
|
|
| EPS (Diluted) |
-56.63
N/A
|
32.88
N/A
|
-7.18
N/A
|
|